320 related articles for article (PubMed ID: 6294213)
1. Analysis of the defects responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished gamma interferon production in response to autologous stimulation.
Hasler F; Bluestein HG; Zvaifler NJ; Epstein LB
J Exp Med; 1983 Jan; 157(1):173-88. PubMed ID: 6294213
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the defects responsible for the impaired regulation of EBV-induced B cell proliferation by rheumatoid arthritis lymphocytes. II. Role of monocytes and the increased sensitivity of rheumatoid arthritis lymphocytes to prostaglandin E.
Hasler F; Bluestein HG; Zvaifler NJ; Epstein LB
J Immunol; 1983 Aug; 131(2):768-72. PubMed ID: 6306107
[TBL] [Abstract][Full Text] [Related]
3. Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect.
Depper JM; Bluestein HG; Zvaifler NJ
J Immunol; 1981 Nov; 127(5):1899-902. PubMed ID: 6271870
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic mechanisms in vitro against Epstein-Barr virus infected lymphoblastoid cell lines in rheumatoid arthritis.
McChesney MB; Bankhurst AD
Ann Rheum Dis; 1986 Jul; 45(7):546-52. PubMed ID: 3017244
[TBL] [Abstract][Full Text] [Related]
5. Different defects of T cell regulation of Epstein-Barr virus-induced B cell activation in rheumatoid arthritis.
Kahan A; Kahan A; Amor B; Menkes CJ
Arthritis Rheum; 1985 Sep; 28(9):961-70. PubMed ID: 2994687
[TBL] [Abstract][Full Text] [Related]
6. Effects of tilomisole, indomethacin and levamisole on regulation of Epstein Barr virus-induced B cell proliferation by peripheral blood mononuclear cells from normal individuals and patients with rheumatoid arthritis.
Gilman SC; Bluestein HG
Agents Actions; 1987 Aug; 21(3-4):266-8. PubMed ID: 2825478
[TBL] [Abstract][Full Text] [Related]
7. Defective control of Epstein-Barr virus-infected B cell growth in patients with X-linked lymphoproliferative disease.
Yasuda N; Lai PK; Rogers J; Purtlo DT
Clin Exp Immunol; 1991 Jan; 83(1):10-6. PubMed ID: 1846327
[TBL] [Abstract][Full Text] [Related]
8. Release of lymphokines after infection with Epstein Barr virus in vitro. II. A monocyte-dependent inhibitor of interleukin 1 downregulates the production of interleukin 2 and interferon-gamma in rheumatoid arthritis.
Lotz M; Tsoukas CD; Fong S; Dinarello CA; Carson DA; Vaughan JH
J Immunol; 1986 May; 136(10):3643-8. PubMed ID: 3009609
[TBL] [Abstract][Full Text] [Related]
9. Diminished IL-2-induced gamma-interferon production by unstimulated peripheral-blood lymphocytes in rheumatoid arthritis.
Hasler F; Dayer JM
Br J Rheumatol; 1988 Feb; 27(1):15-20. PubMed ID: 2827831
[TBL] [Abstract][Full Text] [Related]
10. Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans.
Lotz M; Tsoukas CD; Fong S; Dinarello CA; Carson DA; Vaughan JH
J Immunol; 1986 May; 136(10):3636-42. PubMed ID: 3009608
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of impaired T cell regulation of Epstein-Barr virus stimulated B lymphocytes in rheumatoid arthritis with HLA identical, disease discordant sibling pairs.
Fawcett MC; Walker DJ; Griffiths ID
Ann Rheum Dis; 1988 May; 47(5):372-6. PubMed ID: 2839121
[TBL] [Abstract][Full Text] [Related]
13. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Morishima S; Nakamura S; Yamamoto K; Miyauchi H; Kagami Y; Kinoshita T; Onoda H; Yatabe Y; Ito M; Miyamura K; Nagai H; Moritani S; Sugiura I; Tsushita K; Mihara H; Ohbayashi K; Iba S; Emi N; Okamoto M; Iwata S; Kimura H; Kuzushima K; Morishima Y
Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317
[TBL] [Abstract][Full Text] [Related]
14. Increased responsiveness of rheumatoid B lymphocytes to stimulation by Epstein-Barr virus.
Stierle HE; Brown KA; Perry JD; Holborow EJ
Rheumatol Int; 1983; 3(1):7-11. PubMed ID: 6310725
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus infection transforms CD25+ B cells into antibody-secreting cells in rheumatoid arthritis patients.
Brisslert M; Rehnberg M; Bokarewa MI
Immunology; 2013 Dec; 140(4):421-9. PubMed ID: 23844744
[TBL] [Abstract][Full Text] [Related]
16. B-cell-derived interleukin 1 (IL-1)-like factor. I. Relationship of production of IL-1-like factor to accessory cell function of Epstein-Barr virus-transformed human B-lymphoblast lines.
Matsushima K; Kuang YD; Tosato G; Hopkins SJ; Oppenheim JJ
Cell Immunol; 1985 Sep; 94(2):406-17. PubMed ID: 2992808
[TBL] [Abstract][Full Text] [Related]
17. [What is the role of Epstein-Barr virus in the pathogenesis of connective tissue diseases?].
Sany J
Presse Med; 1987 Apr; 16(15):725-8. PubMed ID: 3033628
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
Konttinen YT; Bluestein HG; Zvaifler NJ
J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
[TBL] [Abstract][Full Text] [Related]
20. The effects of adherent cells on measurement of the hyper-responsiveness of rheumatoid B lymphocytes to Epstein-Barr virus.
Winrow VR; Norton J; Perry JD; Holborow EJ; Stierle HE
J Immunol Methods; 1987 Mar; 97(2):221-7. PubMed ID: 3029230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
